Skip to main content
. 2017 Oct 10;84(1):18–24. doi: 10.1111/bcp.13402

Table 1.

Baseline characteristics of the studied population (n = 98)

Non‐adherent Poorly adherent Adherent
n = 16 n = 52 n = 30
Age (years) 57 (13) 65 (9) 63 (11)
Sex male * 7 (44) 22 (43) 12 (39)
Ethnicity Caucasian * 14 (88) 50 (98) 29 (94)
Cardiovascular history * 7 (44) 24 (47) 16 (52)
Diabetes Mellitus * 4 (25) 19 (37) 5 (16)
Current smoking * 4 (25) 11 (22) 4 (13)
Body mass index (kg m –2 ) 28.5 (5.2) 29.1 (5.0) 29.1 (4.7)
No. of BP lowering drugs 3.9 (1.3) 4.0 (0.9) 2.6 (1.7)
No. of classes of BP lowering drugs 3.4 (1.0) 3.7 (0.8) 2.7 (1.6)
Office BP
Systolic (mmHg) 184 (28) 162 (22) 165 (24)
Diastolic (mmHg) 106 (22) 89 (14) 92 (13)
Heart rate (bpm) 76 (11) 69 (12) 68 (12)
24‐h ABPM
Systolic (mmHg) 162 (17) 155 (15) 158 (19)
Diastolic (mmHg) 96 (17) 88 (15) 89 (13)
Heart rate (bpm) 70 (12) 70 (11) 68 (12)
Daytime ABPM
Systolic (mmHg) 167 (17) 158 (15) 161 (19)
Diastolic (mmHg) 100 (18) 90 (15) 91 (14)
Heart rate (bpm) 72 (12) 72 (11) 70 (12)
Night time ABPM
Systolic (mmHg) 149 (21) 143 (15) 148 (18)
Diastolic (mmHg) 85 (14) 79 (13) 82 (13)
Heart rate (bpm) 65 (12) 65 (9) 62 (9)
LDL (mmol l –1 ) 2.8 (0.7) 3.1 (1.2) 3.2 (1.1)
eGFR ( ml min –1  1.73 m –2 ) 91 (15) 74 (17) 74 (20)
Renal denervation * 10 (63) 33 (65) 20 (65)

Data are expressed as mean ± standard deviation, unless stated otherwise.

*

Data are expressed as number of patients (%).

No., number; BP, blood pressure; bpm, beats per minute; ABPM, ambulatory BP measurement; LDL, low‐density lipoprotein; eGFR, estimated glomerular filtration rate